Stefan K.F. Schwabe
2016
In 2016, Stefan K.F. Schwabe earned a total compensation of $1.2M as Executive Vice President of Research and Development, Chief Medical Officer at Supernus Pharmaceuticals, a 23% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $159,000 |
|---|---|
| Option Awards | $649,000 |
| Salary | $366,583 |
| Other | $41,082 |
| Total | $1,215,665 |
Schwabe received $649K in option awards, accounting for 53% of the total pay in 2016.
Schwabe also received $159K in non-equity incentive plan, $366.6K in salary and $41.1K in other compensation.
Rankings
In 2016, Stefan K.F. Schwabe's compensation ranked 7,314th out of 14,075 executives tracked by ExecPay. In other words, Schwabe earned more than 48.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,314 out of 14,075 | 48th |
Division Manufacturing | 2,759 out of 5,486 | 50th |
Major group Chemicals And Allied Products | 903 out of 1,900 | 53rd |
Industry group Drugs | 702 out of 1,543 | 55th |
Industry Pharmaceutical Preparations | 558 out of 1,173 | 52nd |
Source: SEC filing on April 27, 2017.
Schwabe's colleagues
We found four more compensation records of executives who worked with Stefan K.F. Schwabe at Supernus Pharmaceuticals in 2016.